Spotlight session: Supply chain readiness for distribution of off-the-shelf therapies at scale

As allogeneic and other off-the-shelf therapies progress toward commercialization, supply chain readiness becomes a critical determinant of success. From cold chain logistics to quality oversight, distribution networks must evolve to meet the demands of high-volume, global deployment. This spotlight session explores strategies for building scalable, compliant, and resilient supply chains for advanced therapies. 

Key takeaways: 

• Identify key challenges in scaling distribution for off-the-shelf therapies. 

• Explore cold chain and storage requirements that ensure product integrity. 

• Assess frameworks for quality assurance and regulatory compliance in distribution. 

• Examine models for global logistics and coordinated delivery at scale. 

• Discuss strategies to mitigate risk and improve resilience in advanced therapy supply chains.